Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Salemi, Giuseppe ^a   Gueli, Maria Concetta ^a   Vitale, Francesco ^a   Battaglieri, Floriana ^a   Guglielmini, Egidio ^a   Ragonese, Paolo ^a   Trentacosti, Angela ^a   Massenti, Maria Fatima ^a   Savettieri, Giovanni ^a   Bono, Antonino ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; RETINOL; TRIACYLGLYCEROL; URIC ACID; VITAMIN; ANTIOXIDANT;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CELL DAMAGE; CELL STRESS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMOBILIZATION; IMMUNOREGULATION; LIPID BLOOD LEVEL; MALE; MULTIPLE SCLEROSIS; NEUROPROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CHEMISTRY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; TRIGLYCERIDES; URIC ACID; VITAMINS;

EID: 77949290021     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-19     Document Type: Article

References (11)

1. Altered Uric Acid Levels and Disease States. MK Kutzing BL Firestein, Journal of Pharmacology and Experimental Therapy 2008 324 1 7 10.1124/jpet.107.129031
2. Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. FJ Jimenez-Jimenez F de Bustos JA Molina C de Andrés T Gasalla M Ortí-Pareja M Zurdo J Porta F Castellano-Milln J Arenas R Enríquez de Salamanca, Neuroscience Letters 1998 249 65 67 10.1016/S0304-3940(98)00370-X 9672390
3. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. HT Besler S Comoglu Z Okcu, Nutritional Neuroscience 2002 5 215 220 10.1080/10284150290029205 12041878
4. Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis. W Royal S Gartner CD Gajewski, Multiple Sclerosis 2002 8 452 458 10.1191/1352458502ms858oa 12474982
5. Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. M Vrethem E Mattsson H Hebelka K Leerbeck A Osterberg AM Landtblom B Balla H Nilsson M Hultgren L Brattström B Kågedal, Multiple Sclerosis 2003 9 239 245 10.1191/1352458503ms918oa 12814169
6. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. F Giubilei G Antonini S Di Legge MP Sormani P Pantano R Antonini M Sepe-Monti F Caramia C Pozzilli, Acta Neurologica Scandinavica 2002 106 109 112 10.1034/j.1600-0404.2002.01334.x 12100371
7. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses. JP Mostert GS Ramsaransing DJ Heersema M Heerings N Wilczak J De Keyser, Journal of Neurological Sciences 2005 231 41 44 10.1016/j.jns.2004.12.008
8. Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis. K Rejdak A Petzold Z Stelmasiak G Giovannoni, Mult Scler 2008 14 59 66 10.1177/1352458507082061 17893112
9. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. JB Ubbink VW Hayward S Bissbort, Journal of Chromatography 1991 565 441 446 10.1016/0378-4347(91)80407-4 1874890
10. Lipoprotein physiology. HN Ginsberg, Endocrinology Metabolism Clinical of North America 1998 27 503 519 10.1016/S0889-8529(05)70023-2
11. Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. AM Amorini A Petzold B Tavazzi J Eikelenboom G Keir A Belli G Giovannoni V Di Pietro C Polman S D'Urso R Vagnozzi B Uitdehaag G Lazzarino, Clin Biochem 2009 42 1001 6 10.1016/j.clinbiochem.2009.03.020 19341721